Immunosuppressant FK506 activates NF-κB through the proteasome-mediated degradation of IκBα. Requirement for IκBα N-terminal phosphorylation but not ubiquitination sites

Yong Kang Zhang, Xiangao Sun, Kei Ichi Muraoka, Akiko Ikeda, Shigeki Miyamoto, Hiroko Shimizu, Katsuji Yoshioka, Ken-ichi Yamamoto

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The immunosuppressant FK506 activates NF-κB through IκBα degradation in nonlymphoid cells. In the present study, we analyzed mechanisms by which FK506 induces IκBα degradation. We found that FK506 induces the degradation of both IκBα and IκBβ and that the time courses of the FK506-induced degradation are quite different from degradation induced by interleukin 1 (IL-1). Despite this difference, FK506-induced IκBα degradation was dependent on the N-terminal Ser-32 and Ser-36 phosphorylation sites and was mediated by proteasomes, as is the case for IL-1-induced IκBα degradation. We further showed that FK506 induces weak and slow phosphorylation of IκBα at Ser-32. However, unlike IL-1-induced degradation, IKK-1 and IKK-2 were not activated significantly nor was FK506-induced IκBα degradation dependent on the N-terminal ubiquitination sites (Lys-21 and Lys-22). These results therefore indicate that FK506 and IL-1 utilize similar but distinct mechanisms to induce the phosphorylation and degradation of IκBα.

Original languageEnglish
Pages (from-to)34657-34662
Number of pages6
JournalJournal of Biological Chemistry
Volume274
Issue number49
DOIs
Publication statusPublished - Dec 3 1999
Externally publishedYes

Fingerprint

Phosphorylation
Ubiquitination
Tacrolimus
Proteasome Endopeptidase Complex
Immunosuppressive Agents
Degradation
Interleukin-1

ASJC Scopus subject areas

  • Biochemistry

Cite this

Immunosuppressant FK506 activates NF-κB through the proteasome-mediated degradation of IκBα. Requirement for IκBα N-terminal phosphorylation but not ubiquitination sites. / Zhang, Yong Kang; Sun, Xiangao; Muraoka, Kei Ichi; Ikeda, Akiko; Miyamoto, Shigeki; Shimizu, Hiroko; Yoshioka, Katsuji; Yamamoto, Ken-ichi.

In: Journal of Biological Chemistry, Vol. 274, No. 49, 03.12.1999, p. 34657-34662.

Research output: Contribution to journalArticle

Zhang, Yong Kang ; Sun, Xiangao ; Muraoka, Kei Ichi ; Ikeda, Akiko ; Miyamoto, Shigeki ; Shimizu, Hiroko ; Yoshioka, Katsuji ; Yamamoto, Ken-ichi. / Immunosuppressant FK506 activates NF-κB through the proteasome-mediated degradation of IκBα. Requirement for IκBα N-terminal phosphorylation but not ubiquitination sites. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 49. pp. 34657-34662.
@article{3cc5c54ccfc140768279170af5174d06,
title = "Immunosuppressant FK506 activates NF-κB through the proteasome-mediated degradation of IκBα. Requirement for IκBα N-terminal phosphorylation but not ubiquitination sites",
abstract = "The immunosuppressant FK506 activates NF-κB through IκBα degradation in nonlymphoid cells. In the present study, we analyzed mechanisms by which FK506 induces IκBα degradation. We found that FK506 induces the degradation of both IκBα and IκBβ and that the time courses of the FK506-induced degradation are quite different from degradation induced by interleukin 1 (IL-1). Despite this difference, FK506-induced IκBα degradation was dependent on the N-terminal Ser-32 and Ser-36 phosphorylation sites and was mediated by proteasomes, as is the case for IL-1-induced IκBα degradation. We further showed that FK506 induces weak and slow phosphorylation of IκBα at Ser-32. However, unlike IL-1-induced degradation, IKK-1 and IKK-2 were not activated significantly nor was FK506-induced IκBα degradation dependent on the N-terminal ubiquitination sites (Lys-21 and Lys-22). These results therefore indicate that FK506 and IL-1 utilize similar but distinct mechanisms to induce the phosphorylation and degradation of IκBα.",
author = "Zhang, {Yong Kang} and Xiangao Sun and Muraoka, {Kei Ichi} and Akiko Ikeda and Shigeki Miyamoto and Hiroko Shimizu and Katsuji Yoshioka and Ken-ichi Yamamoto",
year = "1999",
month = "12",
day = "3",
doi = "10.1074/jbc.274.49.34657",
language = "English",
volume = "274",
pages = "34657--34662",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "49",

}

TY - JOUR

T1 - Immunosuppressant FK506 activates NF-κB through the proteasome-mediated degradation of IκBα. Requirement for IκBα N-terminal phosphorylation but not ubiquitination sites

AU - Zhang, Yong Kang

AU - Sun, Xiangao

AU - Muraoka, Kei Ichi

AU - Ikeda, Akiko

AU - Miyamoto, Shigeki

AU - Shimizu, Hiroko

AU - Yoshioka, Katsuji

AU - Yamamoto, Ken-ichi

PY - 1999/12/3

Y1 - 1999/12/3

N2 - The immunosuppressant FK506 activates NF-κB through IκBα degradation in nonlymphoid cells. In the present study, we analyzed mechanisms by which FK506 induces IκBα degradation. We found that FK506 induces the degradation of both IκBα and IκBβ and that the time courses of the FK506-induced degradation are quite different from degradation induced by interleukin 1 (IL-1). Despite this difference, FK506-induced IκBα degradation was dependent on the N-terminal Ser-32 and Ser-36 phosphorylation sites and was mediated by proteasomes, as is the case for IL-1-induced IκBα degradation. We further showed that FK506 induces weak and slow phosphorylation of IκBα at Ser-32. However, unlike IL-1-induced degradation, IKK-1 and IKK-2 were not activated significantly nor was FK506-induced IκBα degradation dependent on the N-terminal ubiquitination sites (Lys-21 and Lys-22). These results therefore indicate that FK506 and IL-1 utilize similar but distinct mechanisms to induce the phosphorylation and degradation of IκBα.

AB - The immunosuppressant FK506 activates NF-κB through IκBα degradation in nonlymphoid cells. In the present study, we analyzed mechanisms by which FK506 induces IκBα degradation. We found that FK506 induces the degradation of both IκBα and IκBβ and that the time courses of the FK506-induced degradation are quite different from degradation induced by interleukin 1 (IL-1). Despite this difference, FK506-induced IκBα degradation was dependent on the N-terminal Ser-32 and Ser-36 phosphorylation sites and was mediated by proteasomes, as is the case for IL-1-induced IκBα degradation. We further showed that FK506 induces weak and slow phosphorylation of IκBα at Ser-32. However, unlike IL-1-induced degradation, IKK-1 and IKK-2 were not activated significantly nor was FK506-induced IκBα degradation dependent on the N-terminal ubiquitination sites (Lys-21 and Lys-22). These results therefore indicate that FK506 and IL-1 utilize similar but distinct mechanisms to induce the phosphorylation and degradation of IκBα.

UR - http://www.scopus.com/inward/record.url?scp=0033521112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033521112&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.49.34657

DO - 10.1074/jbc.274.49.34657

M3 - Article

VL - 274

SP - 34657

EP - 34662

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 49

ER -